Posts

Showing posts with the label Herpes Simplex Virus Treatment Market 2030

Herpes Simplex Virus Treatment Market Overview By Type, Drug, Vaccine, Route Of Administration, End-Use, Region And Forecast

Image
  San Francisco, 1 March 2024:  The Report  Herpes Simplex Virus Treatment Market  Size, Share & Trends Analysis Report By Type (HSV-1, HSV-2), By Drug (Acyclovir, Valacyclovir, Famciclovir), By Vaccine (Simplirix, Others), By Route of Administration, By End-use, By Region, And Segment Forecasts, 2024 - 2030 The global herpes simplex virus treatment market size is expected to reach USD 4.08 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2024 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market. According to the WHO, in 2020, nearly 491.5 million peopl

Herpes Simplex Virus Treatment Market Projected To Raise At USD 3.13 Billion By 2030

Image
  San Francisco, 4 Aug 2023:  The Report  Herpes Simplex Virus Treatment Market  Size, Share & Trends Analysis Report By Treatment (HSV-1, HSV-2), By Drug, By Vaccine, By Route of Administration, By End-use, By Region, And Segment Forecasts, 2023 - 2030 The global herpes simplex virus treatment market size is expected to reach USD 3.13 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.24% from 2023 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market. According to the WHO, in 2020, nearly 491.5 million people were suffering from genital herpes caused by the herp